Uroonkoloji Bulteni-Bulletin of Urooncology

Scope & Guideline

Fostering global collaboration for breakthroughs in uro-oncology.

Introduction

Delve into the academic richness of Uroonkoloji Bulteni-Bulletin of Urooncology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2147-2270
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationUROONKOLOJI BUL / Uroonkoloji Bul.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The journal 'Uroonkoloji Bulteni-Bulletin of Urooncology' primarily aims to advance the field of urooncology through the dissemination of high-quality research and clinical practice insights. It focuses on a wide array of topics related to urological cancers, emphasizing both innovative diagnostic techniques and treatment strategies.
  1. Urological Cancer Research:
    The journal focuses on various types of urological cancers, including prostate, bladder, and renal cancers, providing insights into their epidemiology, pathophysiology, and management.
  2. Clinical Outcomes and Prognostic Factors:
    Research published often explores clinical outcomes related to different treatment modalities, emphasizing the identification of prognostic factors that can guide patient management.
  3. Surgical Techniques and Innovations:
    The journal highlights advancements in surgical techniques, including minimally invasive approaches, robotic surgery, and their impact on patient outcomes.
  4. Diagnostic Imaging and Biomarkers:
    There is a strong emphasis on the role of diagnostic imaging, particularly multiparametric MRI, and the use of biomarkers in the early detection and monitoring of urological cancers.
  5. Multidisciplinary Approaches:
    The journal promotes a multidisciplinary approach to urooncology, integrating insights from urology, medical oncology, pathology, and radiology to improve patient care and outcomes.
The journal has shown a dynamic evolution in its focus, with several emerging themes that reflect current trends in urooncology research and clinical practice.
  1. Impact of COVID-19 on Urological Care:
    Recent publications have increasingly addressed the impact of the COVID-19 pandemic on surgical delays and oncological outcomes, highlighting the need for adaptive strategies in patient management.
  2. Multiparametric MRI Applications:
    There is a growing trend towards utilizing multiparametric MRI for better diagnostic accuracy and treatment planning in prostate cancer, reflecting advancements in imaging technology.
  3. Biochemical Recurrence and Predictive Models:
    Research on biochemical recurrence and the development of predictive models for recurrence post-treatment is gaining traction, emphasizing the importance of follow-up care and patient stratification.
  4. Inflammatory Markers and Prognosis:
    Emerging studies are focusing on the prognostic value of inflammatory markers in bladder cancer and other urological cancers, indicating a trend towards integrating inflammatory responses in cancer prognosis.
  5. Patient-Centric Approaches and Quality of Life:
    There is an increasing focus on patient-reported outcomes and quality of life assessments in the context of urological cancer treatment, highlighting a shift towards more holistic patient care.

Declining or Waning

While 'Uroonkoloji Bulteni-Bulletin of Urooncology' has maintained a robust focus on various aspects of urooncology, some themes appear to be declining in prominence based on recent publications.
  1. Pediatric Urological Oncology:
    There has been a noticeable decrease in publications focusing on pediatric urological cancers, suggesting a waning interest or fewer cases being reported.
  2. Rare Urological Tumors:
    Research pertaining to rare urological tumors, such as adenomatoid tumors or rare testicular cancers, appears to be less frequent, indicating a possible shift towards more common conditions.
  3. Historical Treatment Comparisons:
    There is a declining emphasis on historical comparisons of treatment modalities, with more focus on current practices and innovations rather than retrospective analyses.

Similar Journals

European Urology Focus

Innovating research to shape the future of urology.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

European Urology Focus is a premier journal published by Elsevier, dedicated to advancing the field of urology. With its inception dating back to 2015 and a convergence period extending through 2024, this journal has rapidly established itself as a leading platform within the medical community, boasting an impressive Scopus ranking of #5 out of 120 in Urology, placing it in the 96th percentile. The journal is recognized for its impactful contributions to urological research, and it is classified in the prestigious Q1 category for Urology in 2023. Based in the Netherlands, European Urology Focus prioritizes innovative research, reviews, and clinical observations, catering not only to seasoned professionals but also to emerging scholars and practitioners in the field. While traditionally a subscription-based journal, it offers flexible access options tailored for its diverse readership. With a commitment to enhancing knowledge and improving patient outcomes in urological health, European Urology Focus stands as a vital resource for those engaged in this essential area of medicine.

Advances in Urology

Fostering Collaboration in Urological Advancements
Publisher: HINDAWI LTDISSN: 1687-6369Frequency: 1 issue/year

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

Urology Research and Practice

Unveiling cutting-edge discoveries in urology.
Publisher: AVESISSN: Frequency: 6 issues/year

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Elevating the standard of care with peer-reviewed discoveries.
Publisher: ELSEVIER SCIENCE INCISSN: 1078-1439Frequency: 12 issues/year

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

Annals of Hepato-Biliary-Pancreatic Surgery

Your Gateway to Cutting-Edge Research in Surgery
Publisher: Korean Assoc Hepato-Biliary-Pancreatic Surgery KAHBPSISSN: 2508-5778Frequency: 4 issues/year

Annals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.

Annals of Gastroenterological Surgery

Advancing Gastrointestinal Surgery Through Open Access Innovation
Publisher: WILEY-V C H VERLAG GMBHISSN: 2475-0328Frequency: 6 issues/year

Annals of Gastroenterological Surgery is a premier open-access journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the field of gastrointestinal surgery through innovative research, comprehensive reviews, and clinical studies. Since its inception in 2017, the journal has quickly established itself as a leading platform, achieving a commendable Q1 ranking in both Gastroenterology and Surgery, with significant impact reflected in its Scopus Ranks, positioning it within the 87th and 69th percentiles, respectively. With its focus on high-quality, accessible research, the Annals of Gastroenterological Surgery invites researchers, professionals, and students from around the globe to contribute and share their findings, ensuring that important advancements in surgical techniques and patient care are broadly disseminated. The journal's open-access model enhances its reach and impact, enabling a wider audience to benefit from cutting-edge developments in the field. As the journal converges towards its 2024 volume, it continues to uphold the highest standards in publication, making it an indispensable resource for anyone involved in the disciplines of gastroenterology and surgical practice.

SURGICAL ONCOLOGY-OXFORD

Bridging surgical excellence and oncological advancements.
Publisher: ELSEVIER SCI LTDISSN: 0960-7404Frequency: 4 issues/year

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

ARCHIVOS ESPANOLES DE UROLOGIA

Navigating the Landscape of Urological Advancements
Publisher: INIESTARES, S.A.ISSN: 0004-0614Frequency: 10 issues/year

ARCHIVOS ESPANOLES DE UROLOGIA, published by INIESTARES, S.A., serves as a key academic resource for urology and related medical fields. With an impressive history dating back to 1945, this journal has evolved to address the ongoing advancements and challenges in the field of urology, making crucial contributions to medical knowledge and practice. Although classified in category quartile Q3 for Urology and Q4 for Medicine (miscellaneous), the journal's commitment to quality research is reflected in its diverse range of topics, which are geared toward practitioners, researchers, and students alike. While it does not currently operate under an open access model, the insights and findings presented in its articles are indispensable for anyone looking to deepen their understanding of urological medicine. With a Scopus rank of #84 out of 120 in Urology, this journal continues to be an essential platform for disseminating significant research and fostering academic dialogue in the Spanish medical community and beyond.

Gland Surgery

Advancing surgical excellence in gland-related procedures.
Publisher: AME PUBLISHING COMPANYISSN: 2227-684XFrequency: 12 issues/year

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

Translational Andrology and Urology

Innovating Patient Care through Groundbreaking Research
Publisher: AME PUBLISHING COMPANYISSN: 2223-4683Frequency: 6 issues/year

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.